ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 95 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2016. The put-call ratio across all filers is 1.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,101,000 | -3.1% | 136,540 | 0.0% | 0.00% | -25.0% |
Q1 2021 | $1,136,000 | -40.5% | 136,540 | -45.8% | 0.00% | -33.3% |
Q4 2020 | $1,908,000 | -28.9% | 251,740 | 0.0% | 0.01% | -40.0% |
Q3 2020 | $2,684,000 | -29.8% | 251,740 | -0.2% | 0.01% | -41.2% |
Q2 2020 | $3,826,000 | +1.7% | 252,365 | -44.1% | 0.02% | -19.0% |
Q1 2020 | $3,763,000 | -50.7% | 451,740 | 0.0% | 0.02% | -40.0% |
Q4 2019 | $7,634,000 | -9.0% | 451,740 | 0.0% | 0.04% | -20.5% |
Q3 2019 | $8,389,000 | -25.7% | 451,740 | -8.5% | 0.04% | -29.0% |
Q2 2019 | $11,297,000 | -2.0% | 493,740 | -10.0% | 0.06% | +3.3% |
Q1 2019 | $11,532,000 | +82.8% | 548,600 | 0.0% | 0.06% | +57.9% |
Q4 2018 | $6,309,000 | -49.9% | 548,600 | 0.0% | 0.04% | -37.7% |
Q3 2018 | $12,590,000 | +2.9% | 548,600 | 0.0% | 0.06% | -11.6% |
Q2 2018 | $12,234,000 | -2.4% | 548,600 | 0.0% | 0.07% | -18.8% |
Q1 2018 | $12,536,000 | -21.4% | 548,600 | -9.9% | 0.08% | -19.0% |
Q4 2017 | $15,945,000 | +6.2% | 608,600 | -9.0% | 0.10% | -2.8% |
Q3 2017 | $15,010,000 | -17.9% | 668,600 | 0.0% | 0.11% | -22.3% |
Q2 2017 | $18,286,000 | +2.0% | 668,600 | -9.8% | 0.14% | 0.0% |
Q1 2017 | $17,932,000 | +16.6% | 741,000 | 0.0% | 0.14% | +3.7% |
Q4 2016 | $15,376,000 | -23.9% | 741,000 | 0.0% | 0.13% | -28.7% |
Q3 2016 | $20,200,000 | +85.4% | 741,000 | -2.1% | 0.19% | +77.4% |
Q2 2016 | $10,893,000 | +0.1% | 757,000 | 0.0% | 0.11% | +1.9% |
Q1 2016 | $10,878,000 | -33.1% | 757,000 | 0.0% | 0.10% | -37.7% |
Q4 2015 | $16,268,000 | +32.8% | 757,000 | 0.0% | 0.17% | +8.4% |
Q3 2015 | $12,248,000 | -37.3% | 757,000 | 0.0% | 0.15% | -31.2% |
Q2 2015 | $19,538,000 | +13.1% | 757,000 | -1.4% | 0.22% | +13.7% |
Q1 2015 | $17,280,000 | +15.7% | 768,000 | -1.3% | 0.20% | +10.7% |
Q4 2014 | $14,930,000 | -12.4% | 778,000 | -1.9% | 0.18% | -18.7% |
Q3 2014 | $17,034,000 | -17.4% | 793,000 | 0.0% | 0.22% | -37.1% |
Q2 2014 | $20,618,000 | +19.2% | 793,000 | 0.0% | 0.35% | +10.1% |
Q1 2014 | $17,295,000 | +78.7% | 793,000 | -0.0% | 0.32% | +62.9% |
Q4 2013 | $9,678,000 | -9.0% | 793,300 | 0.0% | 0.19% | -19.5% |
Q3 2013 | $10,638,000 | +65.1% | 793,300 | 0.0% | 0.24% | +51.6% |
Q2 2013 | $6,442,000 | – | 793,300 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 2,065,560 | $39,638,000 | 23.01% |
Selkirk Management LLC | 165,700 | $3,180,000 | 1.90% |
Opaleye Management Inc. | 100,000 | $1,919,000 | 0.97% |
LUCUS ADVISORS LLC | 80,000 | $1,535,000 | 0.68% |
Miura Global Management | 435,000 | $8,348,000 | 0.63% |
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 276,549 | $5,307,000 | 0.48% |
Iguana Healthcare Management, LLC | 50,000 | $960,000 | 0.46% |
BSW Wealth Partners | 22,714 | $436,000 | 0.35% |
FAIRFIELD, BUSH & CO. | 35,100 | $674,000 | 0.19% |
Harvest Capital Strategies LLC | 90,000 | $1,727,000 | 0.19% |